GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biovica International AB (STU:9II) » Definitions » Revenue per Share

Biovica International AB (STU:9II) Revenue per Share : €0.01 (TTM As of Jan. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Biovica International AB Revenue per Share?

Biovica International AB's revenue per share for the three months ended in Jan. 2025 was €0.00. Biovica International AB's revenue per share for the trailing twelve months (TTM) ended in Jan. 2025 was €0.01.

Warning Sign:

Biovica International AB revenue per share is in decline over the past 12 months.

During the past 12 months, the average Revenue Per Share Growth Rate of Biovica International AB was -36.80% per year. During the past 3 years, the average Revenue Per Share Growth Rate was 20.70% per year. During the past 5 years, the average Revenue Per Share Growth Rate was -0.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.

The historical rank and industry rank for Biovica International AB's Revenue per Share or its related term are showing as below:

STU:9II' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -24   Med: 12.6   Max: 79.4
Current: 20.7

During the past 10 years, Biovica International AB's highest 3-Year average Revenue Per Share Growth Rate was 79.40% per year. The lowest was -24.00% per year. And the median was 12.60% per year.

STU:9II's 3-Year Revenue Growth Rate is ranked better than
75.36% of 767 companies
in the Biotechnology industry
Industry Median: 3.2 vs STU:9II: 20.70

Biovica International AB Revenue per Share Historical Data

The historical data trend for Biovica International AB's Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biovica International AB Revenue per Share Chart

Biovica International AB Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.01 0.01 0.01 0.01

Biovica International AB Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Biovica International AB's Revenue per Share

For the Biotechnology subindustry, Biovica International AB's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biovica International AB's PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biovica International AB's PS Ratio distribution charts can be found below:

* The bar in red indicates where Biovica International AB's PS Ratio falls into.



Biovica International AB Revenue per Share Calculation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Biovica International AB's Revenue Per Share for the fiscal year that ended in Apr. 2024 is calculated as

Revenue Per Share (A: Apr. 2024 )=Revenue (A: Apr. 2024 )/Shares Outstanding (Diluted Average) (A: Apr. 2024 )
=0.628/58.408
=0.01

Biovica International AB's Revenue Per Share for the quarter that ended in Jan. 2025 is calculated as

Revenue Per Share (Q: Jan. 2025 )=Revenue (Q: Jan. 2025 )/Shares Outstanding (Diluted Average) (Q: Jan. 2025 )
=0.197/97.786
=0.00

Revenue per Share for the trailing twelve months (TTM) ended in Jan. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biovica International AB  (STU:9II) Revenue per Share Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Biovica International AB Revenue per Share Related Terms

Thank you for viewing the detailed overview of Biovica International AB's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Biovica International AB Business Description

Traded in Other Exchanges
Address
Dag Hammarskjolds vag 54B, Uppsala Science Park, Uppsala, SWE, 752 37
Biovica International AB is a biotech company. The company develops and commercializes blood-based diagnostic tests with biomarkers that improve the monitoring and evaluation of modern cancer treatments. The company promotes healthcare through collaboration with cancer institutes and pharmaceutical companies. DiviTum is manufactured by the company and sold as a kit consisting of a reaction plate with reagents that have been optimized for ELISA applications.

Biovica International AB Headlines

No Headlines